Country: Malta
Language: English
Source: Medicines Authority
AMINOPHYLLINE HYDRATE
Mercury Pharmaceuticals (Ireland) Limited 4045 Kingswood Road, City West Business Park, Co, Dublin, Ireland
R03DA05
AMINOPHYLLINE HYDRATE 25 mg/ml
SOLUTION FOR INJECTION
AMINOPHYLLINE HYDRATE 25 mg/ml
POM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Withdrawn
2006-08-31
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. The name of your medicine is Aminophylline Hydrate 25mg/ml Solution for injection. It will be referred to as Aminophylline Injection for ease here after. IN THIS LEAFLET: 1. What Aminophylline Injection is and what it is used for 2. Before you are given Aminophylline Injection 3. How Aminophylline Injection is given to you 4. Possible side effects 5. How to store Aminophylline Injection 6. Further information 1. WHAT AMINOPHYLLINE INJECTION IS AND WHAT IT IS USED FOR Aminophylline belongs to a group of medicines called xanthines. It expands the air passages of the lungs, which helps relieve chest tightness and wheezing (bronchospasm). This medicine may be used to relieve difficulty in breathing due to asthma and long term obstruction to the flow of air in the lungs. 2. BEFORE YOU ARE GIVEN AMINOPHYLLINE INJECTION You should not be given Aminophylline Injection if: • you know that you are allergic to Aminophylline hydrate and Xanthine containing medicines or any of the other ingredients in this medicine (as listed in Section 6). Speak to your doctor if this applies to you before you are given Aminophylline Injection. TAKE SPECIAL CARE AND TELL YOUR DOCTOR IF: • you are elderly • you have a heart problem • you have a problem with your kidney or liver • you are a smoker • you have ever had a peptic ulcer • you have ever suffered from seizures/fits (e.g. epilepsy) • you are suffering from a viral infection, suc Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1) NAME OF THE MEDICINAL PRODUCT Aminophylline Hydrate 25mg/ml Solution for Injection 2) QUALITATIVE AND QUANTITATIVE COMPOSITION Each 10ml of solution contains 250mg of Aminophylline Hydrate equivalent to 239.73mg of Aminophylline. Each 1ml of solution contains 25mg Aminophylline Hydrate equivalent to 23.973 mg of Aminophylline. For a full list of excipients, see section 6.1 3) PHARMACEUTICAL FORM Solution for Injection A clear colourless solution. 4) CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In the management of bronchospasm, e.g. in asthma, chronic bronchitis and emphysema. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Aminophylline Injection BP 250mg in 10ml is for slow intravenous administration at a rate not exceeding 25mg per minute. Therapeutic plasma concentrations of theophylline should be maintained in the range of 10 to 20mcg/ml and levels above 20mcg/ml are more likely to be associated with toxic effects. There is a marked interpatient variation in the dosage required to achieve plasma levels of theophylline that are within the desired therapeutic range. During therapy, patients should be monitored carefully for signs of toxicity (see precautions and warnings below) Loading Dose: Adults: FOR PATIENTS NOT CURRENTLY RECEIVING XANTHINE THERAPY an initial dose of 6mg aminophylline/kg should be given at a rate not exceeding 25mg/minute (containing 20mg/minute theophylline). Loading doses are usually given over 20 to 30 minutes. FOR PATIENTS ALREADY RECEIVING XANTHINE THERAPY THE LOADING DOSE MUST BE REDUCED TO AVOID OVERDOSAGE. Ideally, the serum theophylline conc Read the complete document